普莱柯：8月28日召开董事会会议

Group 1 - The company, Pulaike (SH 603566), held its 19th meeting of the 5th board of directors on August 28, 2025, to review the proposal for the full and summary report of the 2025 semi-annual report [1] - For the year 2024, the company's revenue composition is as follows: veterinary biological products account for 96.44%, functional health products account for 1.79%, income from technology licensing or transfer accounts for 0.94%, and other businesses account for 0.83% [1]